Balance Sheet
Cash Flow Statement
Daily Values
DMA 100DMA 200DMA 50Dividend YieldEV to CFOEV to EBITEV to EBITDAEV to FCFEV to RevenueEnterprise ValueMarket Cap to FCFMarket CapitalizationPricePrice to EarningsPrice to Sales
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInvested Capital

Nanobiotix (NBTX) Enterprise Value (2020 - 2026)

Nanobiotix has reported Enterprise Value over the past 8 years, most recently at -$61.4 million for Q4 2025.

  • For Q4 2025, Enterprise Value fell 15.53% year-over-year to -$61.4 million; the TTM value through Dec 2025 reached -$61.4 million, down 15.53%, while the annual FY2025 figure was -$61.4 million, 15.53% down from the prior year.
  • Enterprise Value for Q4 2025 was -$61.4 million at Nanobiotix, down from -$32.6 million in the prior quarter.
  • Over five years, Enterprise Value peaked at -$32.6 million in Q2 2025 and troughed at -$143.5 million in Q2 2021.
  • A 5-year average of -$72.6 million and a median of -$71.2 million in 2025 define the central range for Enterprise Value.
  • Biggest five-year swings in Enterprise Value: plummeted 91.82% in 2023 and later skyrocketed 59.76% in 2025.
  • Year by year, Enterprise Value stood at -$96.0 million in 2021, then skyrocketed by 56.02% to -$42.2 million in 2022, then plummeted by 91.82% to -$81.0 million in 2023, then surged by 34.38% to -$53.1 million in 2024, then fell by 15.53% to -$61.4 million in 2025.
  • Business Quant data shows Enterprise Value for NBTX at -$61.4 million in Q4 2025, -$32.6 million in Q2 2025, and -$53.1 million in Q4 2024.